Divi’s Labs Q4 net profit up 33 pc at Rs 388.23 cr

Pharma major Sun Pharmaceutical Industries on Wednesday reported a 37.12 per cent decline in its consolidated net profit to Rs 399.84 crore Q4.
Photo by Pixabay on Pexels.com

New Delhi, Jun 6 (PTI) Drug firm Divi’s Laboratories on Saturday reported a 32.96 per cent rise in its consolidated net profit to Rs 388.23 crore for the quarter ended March 31, 2020.

The company had posted a net profit of Rs 291.97 crore for the same period previous fiscal, Divi’s Labs said in a BSE filing.

Consolidated total income of the company stood at Rs 1,466.44 crore for the quarter under consideration. It was Rs 1,307.97 crore for the same period year ago.

Net profit for the fiscal year ended March stood at Rs 1,376.54 crore as against Rs 1,352.74 crore in the previous fiscal, Divi’s Labs said.

For the last fiscal, its total income stood at Rs 5,584.05 crore. It was Rs 5,101.89 crore in the previous fiscal, it added.

The company’s board has declared and paid an interim dividend of Rs 16 per share for the financial year 2019-20. No final dividend is recommended. The total dividend payout for the current year amounted to Rs 512.06 crore including dividend tax, Divi’s Labs said.


Leave a Reply